Valeant Pharmaceuticals International

Global Headquarters
Valeant Pharmaceuticals International
One Enterprise
Aliso Viejo, California 92656
United States of America
1.800.548.5100
1.949.461.6000
1.949.461.6609 (fax)

Investor Relations
To reach the Investor Relations department at Valeant or for media inquiries, please call:
Laurie W. Little , Vice President, Investor Relations
1.949.461.6002
ir@valeant.com

US Customer Service
For product related inquiries or to request product information, please call:
US Pharmaceuticals Customer Service
1.800.556.1937
1.949.461.6626 (fax)

Business Hours
Monday through Friday
5 a.m. – 5 p.m. PST

Request Information
Request information on our medical product line, skin care products, and clinical trials.

TARIBAVIRIN and RETIGABINE are products in clinical development. None of them have been found to be safe or effective for the treatment of any disease or illness. They may not be sold or promoted in the United States unless and until they are approved by the FDA. Similar restrictions apply in other countries.